Michael Sticherling
Overview
Explore the profile of Michael Sticherling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
176
Citations
2335
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Krefting F, Welzel J, Thamm J, Tholken K, Wohlrab J, Muller V, et al.
Eur J Dermatol
. 2025 Feb;
34(6):643-650.
PMID: 39912471
Generalized pustular psoriasis (GPP) is a potentially life-threatening orphan disease. Interleukin (IL)-36 is a known pathogenetic key driver of GPP. The IL-36 receptor inhibitor spesolimab has shown efficacy and safety...
3.
Peschel N, Willershausen I, Schliep S, Sticherling M, Schneider H
J Eur Acad Dermatol Venereol
. 2025 Feb;
PMID: 39902929
No abstract available.
4.
Yalcin Mutlu M, Kleyer A, Kroenke G, Fagni F, Temiz S, Meder C, et al.
BMJ Open
. 2025 Jan;
15(1):e088486.
PMID: 39773803
Objectives: Although patients with immune-mediated inflammatory diseases (IMID) are thought to be more susceptible to viral infections, it is unclear whether their presentation differs between patients with IMID and healthy...
5.
Fakhouri S, Zhu H, Li Y, Ronicke M, Rius Rigau A, Dees C, et al.
Arthritis Rheumatol
. 2024 Dec;
PMID: 39722197
Objective: Little is known on the mechanisms necessary to maintain the physiologic adult human skin integrity. This study aims to quantitatively describe anatomic changes in systemic sclerosis (SSc)-skin compared with...
6.
Neurath L, Sticherling M, Schett G, Fagni F
Cytokine Growth Factor Rev
. 2024 Jul;
78:1-13.
PMID: 39068140
Psoriatic arthritis (PsA) is part of the psoriatic disease spectrum and is characterized by a chronic inflammatory process that affects entheses, tendons and joints. Cytokines produced by immune and non-immune...
7.
Corte G, Atzinger A, Temiz S, Noversa de Sousa R, Yalcin Mutlu M, Schoenau V, et al.
RMD Open
. 2024 Jun;
10(2).
PMID: 38862244
Objectives: To assess the presence and anatomical distribution of activated fibroblasts in the joints and entheses of patients with psoriasis with arthralgia and to test how fibroblast activation visualised by...
8.
Fagni F, Tascilar K, Noversa de Sousa R, Bayat S, Sollfrank L, Kleyer A, et al.
Arthritis Rheumatol
. 2024 May;
76(9):1387-1396.
PMID: 38751108
Objective: We assessed and compared molecular tissue changes at the entheses in patients with psoriasis (PsO) and psoriatic arthritis (PsA) and in healthy controls (HCs) in vivo using multispectral optoacoustic...
9.
Passeron T, Reinhardt M, Ehst B, Weiss J, Sluzevich J, Sticherling M, et al.
Br J Dermatol
. 2024 May;
191(5):680-690.
PMID: 38735684
Background: Patients with lichen planus (LP) refractory to available therapies often experience a high disease burden, representing a population with a clear unmet need for new treatments. Objectives: To evaluate...
10.
Traidl S, Hollstein M, Kroeger N, Fischer S, Heratizadeh A, Heinrich L, et al.
J Eur Acad Dermatol Venereol
. 2024 Apr;
39(1):136-144.
PMID: 38661511
Background: There are conflicting data on a potential association between obesity and atopic dermatitis (AD). The purpose of this study was to investigate the relationship between obesity and AD disease...